These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14512124)

  • 1. An overview of targeted treatments in cancer.
    Abou-Jawde R; Choueiri T; Alemany C; Mekhail T
    Clin Ther; 2003 Aug; 25(8):2121-37. PubMed ID: 14512124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular target therapy for malignant tumors].
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular targeted therapy].
    Stenner-Liewen F; Zippelius A; Pestalozzi BC; Knuth A
    Chirurg; 2006 Dec; 77(12):1118-25. PubMed ID: 17109101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.
    Caponigro F; Basile M; de Rosa V; Normanno N
    Anticancer Drugs; 2005 Feb; 16(2):211-21. PubMed ID: 15655420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing resistance to targeted therapy.
    Vidal L; Attard G; Kaye S; De Bono J
    J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
    Druker BJ
    Expert Opin Pharmacother; 2003 Jun; 4(6):963-71. PubMed ID: 12783592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular therapy of breast carcinoma in the advanced phase].
    Foggi P; Amodio A
    Tumori; 2003; 89(4 Suppl):189-91. PubMed ID: 12903589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib mesylate, the first molecularly targeted gene suppressor.
    Pindolia VK; Zarowitz BJ
    Pharmacotherapy; 2002 Oct; 22(10):1249-65. PubMed ID: 12389876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
    Stathopoulos GP
    Oncol Rep; 2002; 9(6):1257-9. PubMed ID: 12375030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract]   [Full Text] [Related]  

  • 13. [Resistance to target-based therapy and its circumvention].
    Nishio K
    Nihon Rinsho; 2004 Jul; 62(7):1343-7. PubMed ID: 15283154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in the current target therapy of malignancies].
    Stukov AN; Gershanovich ML; Filov VA; Imianitov EN
    Vopr Onkol; 2005; 51(5):607-11. PubMed ID: 16756022
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted therapies for the treatment of cancer.
    Kim JA
    Am J Surg; 2003 Sep; 186(3):264-8. PubMed ID: 12946830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineoplastic agents targeting tyrosine kinases].
    Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab.
    Pierobon M; Silvestri A; Spira A; Reeder A; Pin E; Banks S; Parasido E; Edmiston K; Liotta L; Petricoin E
    J Proteome Res; 2014 Jun; 13(6):2846-55. PubMed ID: 24787230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Researchers optimistic about sea change in cancer treatment.
    Stephenson J
    JAMA; 2001 Jun; 285(22):2841-2. PubMed ID: 11401587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Targeted drugs in radiation therapy].
    Favaudon V; Hennequin C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S114-20. PubMed ID: 15679256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies for the treatment of leukemia.
    Stull DM
    Semin Oncol Nurs; 2003 May; 19(2):90-7. PubMed ID: 12830733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.